Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the ...

The company is adding new products treating a range of issues, including HIV, hypertension and behavioral health.

Health Insurance Giant’s Changing Fortunes UnitedHealth Group (NYSE:UNH) is the largest U.S. health insurer by market cap and revenue, and dominates the healthcare industry through its ...

The Howard County Board of Education is suing Eli Lilly and Co., Novo Nordisk, CVS, United Health group and several other ...

Optum Rx is nixing reauthorization requirements for more than 60 additional medications. | The PBM giant's list of drugs ...

The group, which is the accrediting organization for more than 80% of U.S. hospitals and health systems, says the new rules will "dramatically" streamline and simplify the process. Also in the news: ...

Hardman Johnston Global Advisors, an investment management company, released its “Hardman Johnston Global Equity Strategy” ...

Optum Rx officials said they now have eliminated reauthorization requirements for more than 140 chronic disease medications.

UnitedHealth Group’s Optum Rx will remove reauthorization requirements for more than 60 chronic disease medications on July 1.  The cuts are in addition to about 80 reauthorizations Optum Rx ...

Many proposals to reform the PBM industry miss the forest for the trees, experts said this week. Instead, Congress should go ...

UNH expects Optum Rx’s revenues to be between $145.5 billion and $146.5 billion for 2025, and its long-term growth rate to be 5-8%.

The massive PBM is pivoting to a cost-based reimbursement model, which it says will reduce variation in how pharmacies are paid. Pharmacy groups say that depends on the specifics of Optum Rx’s plan.